Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
bisindolylmaleimide inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SLC19A1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of SLC19A1 mRNA | affects expression | 21346803
|
C030371 |
5,6,7,8-tetrahydrofolic acid |
5,6,7,8-tetrahydrofolic acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
C030371 |
5,6,7,8-tetrahydrofolic acid |
5,6,7,8-tetrahydrofolic acid results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
C005984 |
5-methyltetrahydrofolate |
[5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
C005984 |
5-methyltetrahydrofolate |
5-methyltetrahydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
C005984 |
5-methyltetrahydrofolate |
5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D012856 |
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid |
[4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SLC19A1 mRNA | affects expression | 17562736
|
D012435 |
S-Adenosylhomocysteine |
SLC19A1 protein affects the abundance of S-Adenosylhomocysteine | affects abundance | 15705887
|
D012436 |
S-Adenosylmethionine |
SLC19A1 protein affects the abundance of S-Adenosylmethionine | affects abundance | 15705887
|
D019386 |
Alendronate |
Alendronate affects the expression of SLC19A1 mRNA | affects expression | 16079270
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC19A1 mRNA | affects expression | 16483693
|
D001262 |
Atenolol |
Atenolol results in decreased expression of SLC19A1 mRNA | decreases expression | 19616087
|
D001397 |
Azoxymethane |
SLC19A1 gene mutant form results in increased susceptibility to Azoxymethane | increases response to substance | 15705887
|
C504663 |
BGC638 |
BGC638 binds to and results in decreased activity of SLC19A1 protein | affects binding|decreases activity | 16357184
|
C504663 |
BGC638 |
BGC638 binds to and results in decreased activity of SLC19A1 protein | affects binding|decreases activity | 16357184
|
C504662 |
BGC945 |
BGC945 binds to and results in decreased activity of SLC19A1 protein | affects binding|decreases activity | 16357184
|
C504662 |
BGC945 |
BGC945 binds to and results in decreased activity of SLC19A1 protein | affects binding|decreases activity | 16357184
|
C088060 |
bisindolylmaleimide |
bisindolylmaleimide inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
C088060 |
bisindolylmaleimide |
bisindolylmaleimide inhibits the reaction [Phenobarbital inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
C088060 |
bisindolylmaleimide |
bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D002034 |
Bumetanide |
Bumetanide inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D002034 |
Bumetanide |
Bumetanide results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D002220 |
Carbamazepine |
Carbamazepine results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
D002746 |
Chlorpromazine |
Chlorpromazine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D002746 |
Chlorpromazine |
Chlorpromazine results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
D020355 |
Cholates |
Cholates inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D020355 |
Cholates |
Cholates results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D003022 |
Clotrimazole |
Clotrimazole inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D003022 |
Clotrimazole |
Clotrimazole results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol results in decreased expression of SLC19A1 mRNA | decreases expression | 19616087
|
C010920 |
dihydrofolate |
dihydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
C010920 |
dihydrofolate |
dihydrofolate results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D017878 |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid |
[4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D000431 |
Ethanol |
Ethanol results in decreased expression of SLC19A1 mRNA | decreases expression | 19616087
|
D000431 |
Ethanol |
Ethanol results in increased expression of SLC19A1 protein | increases expression | 17449590
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SLC19A1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC19A1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SLC19A1 mRNA | affects expression | 16079270
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SLC19A1 mRNA | decreases expression | 17108234
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of SLC19A1 mRNA | increases expression | 18035473
|
D005492 |
Folic Acid |
[4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D005492 |
Folic Acid |
[4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D005492 |
Folic Acid |
[5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D005492 |
Folic Acid |
Folic Acid affects the expression of SLC19A1 mRNA | affects expression | 17311948
|
D005492 |
Folic Acid |
Folic Acid results in decreased expression of SLC19A1 mRNA | decreases expression | 17616776
|
D005492 |
Folic Acid |
Folic Acid results in decreased expression of SLC19A1 protein | decreases expression | 17616776
|
D005492 |
Folic Acid |
[Indomethacin results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D005492 |
Folic Acid |
[Methotrexate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D005492 |
Folic Acid |
SLC19A1 gene SNP affects the uptake of and affects the localization of Folic Acid | affects localization|affects uptake | 16750224
|
D005492 |
Folic Acid |
SLC19A1 protein results in increased uptake of Folic Acid | increases uptake | 16900951
|
D005492 |
Folic Acid |
SLC19A1 protein affects the uptake of Folic Acid | affects uptake | 16495369
|
D005492 |
Folic Acid |
SLC19A1 protein results in increased transport of Folic Acid | increases transport | 17616776
|
D007213 |
Indomethacin |
[Indomethacin results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of SLC19A1 mRNA | decreases expression | 18927307
|
D008727 |
Methotrexate |
[Methotrexate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid | decreases activity|decreases uptake | 17034785
|
D008727 |
Methotrexate |
SLC19A1 exon mutant form results in decreased susceptibility to Methotrexate | decreases response to substance | 16505119
|
D008727 |
Methotrexate |
SLC19A1 gene SNP affects the susceptibility to Methotrexate | affects response to substance | 17410198
|
D008727 |
Methotrexate |
SLC19A1 protein affects the susceptibility to Methotrexate | affects response to substance | 14679136
|
D008727 |
Methotrexate |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
5,6,7,8-tetrahydrofolic acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
5-methyltetrahydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
bisindolylmaleimide inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
bisindolylmaleimide inhibits the reaction [Phenobarbital inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
Bumetanide inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Carbamazepine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
Chlorpromazine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
Cholates inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Clotrimazole inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
dihydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Methotrexate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Methotrexate results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D008727 |
Methotrexate |
Okadaic Acid inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
Phenobarbital inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D008727 |
Methotrexate |
SLC19A1 protein affects the transport of Methotrexate | affects transport | 14612385
|
D008727 |
Methotrexate |
SLC19A1 protein results in increased susceptibility to Methotrexate | increases response to substance | 14612385
|
D008727 |
Methotrexate |
SLC19A1 protein results in increased uptake of Methotrexate | increases uptake | 17482559 20451541
|
D008727 |
Methotrexate |
Sulfobromophthalein inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Taurocholic Acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D008727 |
Methotrexate |
Tetrachlorodibenzodioxin inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 20451541
|
D008727 |
Methotrexate |
Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of SLC19A1 mRNA | decreases expression | 18548127
|
C085590 |
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine |
SLC19A1 exon mutant form results in decreased susceptibility to N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine analog | decreases response to substance | 16505119
|
D009538 |
Nicotine |
Nicotine results in decreased expression of SLC19A1 mRNA | decreases expression | 19616087
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D019319 |
Okadaic Acid |
Okadaic Acid results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
C085586 |
pemetrexed |
SLC19A1 exon mutant form results in increased susceptibility to pemetrexed | increases response to substance | 16505119
|
D010634 |
Phenobarbital |
bisindolylmaleimide inhibits the reaction [Phenobarbital inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D010634 |
Phenobarbital |
Phenobarbital inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
D020849 |
Raloxifene |
Raloxifene affects the expression of SLC19A1 mRNA | affects expression | 16079270
|
C068874 |
raltitrexed |
SLC19A1 exon mutant form results in decreased susceptibility to raltitrexed | decreases response to substance | 16505119
|
D012643 |
Selenium |
Selenium results in decreased expression of SLC19A1 mRNA | decreases expression | 19244175
|
D013448 |
Sulfobromophthalein |
Sulfobromophthalein inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D013448 |
Sulfobromophthalein |
Sulfobromophthalein results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D013656 |
Taurocholic Acid |
Taurocholic Acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] | affects transport|decreases reaction | 14612385
|
D013656 |
Taurocholic Acid |
Taurocholic Acid results in decreased activity of SLC19A1 protein | decreases activity | 14612385
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC19A1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 20451541
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased activity of SLC19A1 protein | decreases activity | 20451541
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC19A1 mRNA | decreases expression | 20451541
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC19A1 protein | decreases expression | 20451541
|
D013755 |
Tetradecanoylphorbol Acetate |
bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] | decreases reaction|increases uptake | 17482559
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] | decreases reaction|increases uptake | 17482559
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased activity of SLC19A1 protein | decreases activity | 17482559
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of SLC19A1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
27.02 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
27.02 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
27.02 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
27.02 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
27.02 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
27.02 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.89 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.89 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.46 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
3.91 | 17003819 16595132 16316344 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.00 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
4.00 | 16537180 |
MESH:D000236 |
Adenoma |
marker/mechanism |
|
| 16963246 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
6.31 | 16963246 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
6.31 | 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
8.50 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.50 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.14 | 17451421 17308373 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.83 | 15451040 15451039 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.88 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
8.45 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
8.45 | 15579461 17627676 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
8.45 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
8.45 | 15800139 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
4.53 | 15204022 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.54 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.36 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.35 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.63 | 11141031 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.40 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.41 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.00 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.68 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.36 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
4.62 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.62 | 17286800 |
MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
4.18 | 15815632 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16917939 20468076 |
MESH:D001321 |
Autistic Disorder |
|
5-methyltetrahydrofolate |
3.33 | 18461502 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
3.33 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
3.33 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
S-Adenosylhomocysteine |
3.33 | 20468076 16917939 |
MESH:D001321 |
Autistic Disorder |
|
S-Adenosylmethionine |
3.33 | 16917939 19056591 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.52 | 10684365 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
3.88 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.62 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.45 | 15746008 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.54 | 11481608 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.01 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
3.94 | 12524144 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
2.70 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
2.70 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.70 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
pemetrexed |
2.70 | 17465208 17575230 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.70 | 17261762 17893378 17595753 16912660 17440819 15758505 15775269 15572757 17049068 17242785 16837676 17952589 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.70 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
9.83 | 16374292 |
MESH:D002056 |
Burns |
|
Indomethacin |
9.83 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.53 | 15141370 15625704 11239499 16537180 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.47 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.42 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
7.86 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
7.86 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
7.86 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
7.86 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
7.86 | 6705139 20935162 1701930 20007298 17173139 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.25 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.87 | 11352223 14736730 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
pemetrexed |
4.49 | 12023789 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
3.14 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
4.57 | 15482327 12636206 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
4.57 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
3.66 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Atenolol |
10.04 | 15969258 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.04 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.04 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
6.62 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.62 | 15775269 |
MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.25 | 10318961 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
6.45 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.45 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Azoxymethane |
4.55 | 15705887 18075178 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.79 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.76 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.68 | 11181007 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.52 | 17681005 17110522 16105132 15861022 16919318 11677210 17333356 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 21254359 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
7.00 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
7.00 | 21254359 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 21254359 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.69 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
8.69 | 8946559 21254359 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.69 | 12621046 15340226 15668235 16354765 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.15 | 15800139 |
MESH:D003092 |
Colitis |
|
Selenium |
3.32 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
marker/mechanism |
|
| 15705887 |
MESH:D003110 |
Colonic Neoplasms |
|
Azoxymethane |
5.55 | 15824018 12189186 14668109 16818512 15705887 19056647 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
5.55 | 15637740 15625704 15936596 11260862 15963497 15786552 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.55 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 16963246 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azoxymethane |
4.49 | 11076880 10416599 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
4.49 | 16963246 16985020 17116713 17245555 17087956 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
4.49 | 17054584 12606626 11197048 18059344 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
4.49 | 15273666 17454858 16391804 18259882 17159606 16303861 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
7.85 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.85 | 14669216 17141729 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.23 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
6.64 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
6.64 | 10194807 19302082 15513904 11198716 15451040 15451039 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
6.64 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.64 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
6.64 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.55 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
3.83 | 19747007 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.76 | 17474826 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.67 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
4.10 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.10 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
3.54 | 17308373 15920148 17451421 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.35 | 7907874 7237001 |
MESH:D004314 |
Down Syndrome |
marker/mechanism |
|
| 16845273 17431899 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
4.98 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.11 | 16538176 20216337 16538175 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
19.30 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
19.30 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
19.30 | 11743745 10915739 12153990 16109766 11739529 16781746 12540782 10663392 12594235 18071297 2444490 11461765 15619225 19416960 19164858 14725611 19923254 18713872 12958197 11287661 15968718 16081117 19370779 19739265 17562736 17906064 11421492 12705907 14986274 11529661 16177239 11834606 17522070 19420014 16227642 16485898 10774834 14550746 12392966 19085960 16393943 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
19.30 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorpromazine |
19.30 | 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
19.30 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
19.30 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
19.30 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.61 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
7.21 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.21 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.67 | 16326151 17190690 18446180 12774134 18043480 16133044 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.69 | 11991626 10671773 16699067 11535926 17351913 17202747 11595415 17045617 11595431 17329845 17151854 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.56 | 1851702 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.45 | 17881519 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.22 | 9068938 |
MESH:D004487 |
Edema |
|
Indomethacin |
13.05 | 8985016 7907874 10653021 8273558 16100529 7990266 19703484 |
MESH:D004487 |
Edema |
|
Raloxifene |
13.05 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.05 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
13.05 | 8273558 15177302 8113982 9599246 16716910 7812673 11698051 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.42 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
12.90 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.90 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
12.90 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
3.69 | 17301261 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
7.70 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.70 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
4.03 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.26 | 10567023 16328016 17763956 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.52 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.59 | 11298111 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.80 | 19915237 16415921 16538176 18855540 20485159 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
9.64 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
9.64 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
8.75 | 17116037 16628512 15008574 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
8.75 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
9.86 | 19700373 18234410 19439326 17178248 821787 7988514 19620853 20417680 9014606 17465707 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
9.86 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
9.86 | 821787 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.14 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
10.14 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.14 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
9.29 | 3659116 15276670 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.29 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.24 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.41 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
4.41 | 11005569 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.99 | 20485159 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
5.01 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.65 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
10.78 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
10.78 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
10.78 | 17473493 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.18 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.82 | 16946407 15451040 15513904 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.99 | 11858732 |
MESH:D005334 |
Fever |
|
Indomethacin |
3.71 | 17627676 10431976 11852909 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.42 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
7.29 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.29 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.68 | 11298111 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
23.34 | 16983495 |
MESH:D005756 |
Gastritis |
|
Ethanol |
23.34 | 15046732 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
23.34 | 17171786 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
23.34 | 15046732 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.64 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
6.86 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
6.86 | 17312396 |
MESH:D005910 |
Glioma |
|
Indomethacin |
3.02 | 16487511 18371953 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.90 | 11849393 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.11 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.87 | 11248219 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.68 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
3.42 | 15482327 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
9.71 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.71 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
9.71 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.20 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Atenolol |
6.78 | 20082655 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.78 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.91 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.14 | 15633222 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.23 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
11.94 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
11.94 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.94 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.52 | 16863852 16490937 |
MESH:D006561 |
Herpes Simplex |
|
Chlorpromazine |
4.82 | 1682908 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.01 | 17209195 |
MESH:D006712 |
Homocystinuria |
|
5-methyltetrahydrofolate |
6.34 | 17413090 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.49 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.56 | 16959395 15340226 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
15.66 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
15.66 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
15.66 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
15.66 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.23 | 17883296 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.53 | 12524144 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
8.51 | 10459572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
8.51 | 16755160 16397167 16395265 16865747 16433478 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
3.73 | 17546600 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
4.75 | 18773962 |
MESH:D006973 |
Hypertension |
|
Atenolol |
7.70 | 11593098 15237695 11910301 15188945 15969258 14597852 19249413 12022239 15614026 15453913 14700505 12717102 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
7.70 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.70 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
Atenolol |
5.29 | 15237695 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.34 | 16569931 16945680 |
MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.46 | 10318961 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.54 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.87 | 10651667 10647630 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.88 | 16133044 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.02 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.17 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
9.84 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
9.84 | 7812673 3291741 12568917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.84 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
9.84 | 7562506 8273558 11698051 15177302 7812673 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.34 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
9.34 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
3.86 | 18236018 10210152 17994277 11713966 11855677 17329856 11686837 15610444 15831440 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.88 | 15241188 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.70 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.70 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.54 | 16133968 10574470 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
8.46 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
8.46 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
8.46 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.46 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
2.60 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.66 | 9562676 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.75 | 15451040 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.06 | 16973256 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.52 | 10320625 12228301 11703811 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.57 | 16572323 15631656 10785260 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
2.55 | 18360721 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.88 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.23 | 17980183 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.47 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Chlorpromazine |
4.41 | 15342952 17567588 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.23 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
9.60 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
9.60 | 14986274 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
9.60 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.62 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
5.99 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
5.99 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
S-Adenosylmethionine |
5.99 | 15983038 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.99 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.99 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
8.27 | 16610002 16611625 11587558 12969438 12587719 19014921 19460945 19784758 |
MESH:D008107 |
Liver Diseases |
|
Chlorpromazine |
8.27 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
8.27 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
8.27 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.19 | 17207112 17347304 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.82 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
3.77 | 21047994 8742319 19073162 15975961 19812893 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
3.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
4.78 | 6150874 1399818 18308698 17172636 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
4.78 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
2.85 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.54 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Azoxymethane |
5.87 | 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
5.87 | 11497255 16537180 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.87 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.87 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
5.87 | 11062179 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
5.40 | 16628512 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
5.40 | 17718048 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.61 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
5.28 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
5.28 | 8985016 |
MESH:D008382 |
Marfan Syndrome |
|
Atenolol |
5.78 | 19430350 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.22 | 16832597 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.10 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.74 | 18411066 15451040 |
MESH:D001523 |
Mental Disorders |
|
Chlorpromazine |
4.27 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.55 | 9014606 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.59 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.33 | 11903285 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.07 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
3.62 | 12636206 |
MESH:D052016 |
Mucositis |
|
irinotecan |
11.01 | 17159606 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
11.01 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.10 | 16497877 |
MESH:D009175 |
Mycoplasma Infections |
|
Chlorpromazine |
5.51 | 10773494 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.64 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.00 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
4.99 | 20399394 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.07 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.38 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
5.48 | 11239499 16537180 11053908 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.48 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
3.31 | 16365874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
3.68 | 10663608 15625704 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
4.52 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
8.43 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.43 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
5-methyltetrahydrofolate |
10.92 | 17413090 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
10.92 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
10.92 | 19040278 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.22 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.11 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
7.11 | 12349958 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.25 | 8761367 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
8.80 | 16322990 |
MESH:D009503 |
Neutropenia |
|
pemetrexed |
8.80 | 16322990 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.68 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.76 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
7.76 | 14694615 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.37 | 7009135 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
10.51 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
10.51 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
6.78 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.78 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.79 | 15758505 15579764 17823083 17893378 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.20 | 16870215 |
MESH:D010146 |
Pain |
|
Carbamazepine |
9.20 | 15215642 |
MESH:D010146 |
Pain |
|
Indomethacin |
9.20 | 3291741 13679232 17440234 17627676 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.19 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
7.65 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
7.65 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
7.65 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
7.76 | 17883296 15028970 |
MESH:D010195 |
Pancreatitis |
|
Taurocholic Acid |
7.76 | 20035747 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.25 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.83 | 18922899 18404319 8330346 12065085 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.23 | 16537180 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.23 | 16538176 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.71 | 12349958 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.45 | 17145499 17679678 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.23 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.76 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.67 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.43 | 17225004 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.40 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.11 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Azoxymethane |
8.50 | 14668109 19056647 12458338 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.50 | 2563599 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
4.69 | 9014606 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.66 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
8.27 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.27 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.90 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.90 | 16220300 15731164 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.90 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.73 | 11849393 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.84 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
10.96 | 12752131 9591791 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.96 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.25 | 17410198 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.07 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
9.15 | 15728788 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
9.15 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 18990726 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
2.83 | 16641680 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
15.12 | 18551238 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
15.12 | 16876388 15946322 9844417 16938433 19414003 9046859 16180713 |
MESH:D012640 |
Seizures |
|
Ethanol |
15.12 | 9754883 |
MESH:D012640 |
Seizures |
|
Nicotine |
15.12 | 17873105 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
15.12 | 4039156 11442880 3137016 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.34 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
4.74 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
4.74 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
8.32 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.32 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.32 | 18404319 12065085 8985016 11807781 8330346 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
4.65 | 19414003 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.46 | 16709447 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.01 | 16361298 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.75 | 18855540 15057820 19915237 19694795 16415921 16538176 20485159 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.94 | 18209964 16113693 17160473 16184426 10486359 18545984 10215738 15038085 10192188 17638125 16280098 15472012 17207306 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
5.82 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
5.82 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
5.82 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
5.82 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
pemetrexed |
5.82 | 15958060 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.19 | 17918041 17189318 16755016 9211565 11906479 9562338 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
6.19 | 11595431 17918041 11906479 12498302 18181030 16397915 17657623 12500499 18237397 10878458 16934674 17135157 18209962 12467913 18193104 15138204 18726076 16252198 16169175 10423059 1323529 12077510 15255614 18087811 12787963 11595415 17654042 18299717 11523592 17895592 14567935 16631530 10750652 17977527 17627676 18431645 11145282 11729361 16755016 18543354 15104355 16150113 |
MESH:D020521 |
Stroke |
|
Folic Acid |
12.33 | 16517955 |
MESH:D020521 |
Stroke |
|
Raloxifene |
12.33 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
12.33 | 16517955 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.84 | 9754883 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.58 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.18 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.75 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.42 | 12697716 |
MESH:D018382 |
Thyroid Hormone Resistance Syndrome |
|
Atenolol |
5.92 | 9349583 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
6.20 | 11352223 14736730 18791128 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.20 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.72 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.38 | 16785264 11259349 16720336 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.98 | 17979512 15735609 18041664 18305452 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.42 | 10574470 17380554 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.52 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
4.52 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.84 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.54 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.85 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.11 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.72 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.11 | 14671159 15869587 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.26 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.07 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.76 | 15886252 |